|
WASHINGTON (AP) - The Supreme Court on Monday refused to consider a lawsuit alleging two pharmaceutical companies conspired to monopolize the market for a drug used to treat breast cancer.
Consumers who filed the suit asked the justices to consider when an agreement not to market a generic drug is a violation of federal law.
The 2nd U.S. Circuit Court of Appeals upheld a federal judge, who concluded the agreement between the two companies did not restrain trade in violation of federal law.
|